BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg

BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg from the Nexus Healing & Recovery catalog, supplied for controlled in-vitro research workflows.
In stock: 80mg is in stock.
Certificate pending
Final assay values publish here once independent documentation is available. See the verification process.
For in-vitro research use only. Not for human consumption.
KL80 is a Nexus-only blend SKU. Treat chemistry as component-level data inherited from the individual source compounds.
BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg definition
KL80 is a Nexus-only blend SKU. Treat chemistry as component-level data inherited from the individual source compounds. BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg is classified as a multi-peptide blend. Blend of BPC-157, GHK-Cu, TB-500, and KPV; no single molecular formula or molecular weight applies. Supplied for controlled in-vitro research workflows.
No sequence is listed in the current catalog record for this product.
- CAS
- N/A
- MW
- Not listed
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- Not listed
- Purity
- Certificate pending
- Form
- Lyophilized powder
- Class
- Multi-peptide blend
This lyophilized research material is commonly paired with bacteriostatic water for reconstitution workflows.
Add bacteriostatic waterThe dossier.
Compound Overview
KL80 is documented as a Nexus-only blend SKU. Its identity is defined by four listed peptide components and their stated component amounts: BPC-157 10mg, GHK-Cu 50mg, TB-500 10mg, and KPV 10mg. The product is classified as a multi-peptide blend rather than a single isolated chemical entity.
The structural description provided for this SKU is: blend of BPC-157, GHK-Cu, TB-500, and KPV; no single molecular formula or molecular weight applies. That distinction matters for receiving logs, internal sample tracking, research inventory systems, and any downstream documentation that separates component-level chemistry from blend-level catalog identity.
For laboratories evaluating this material, the appropriate interpretation is component-level. BPC-157 is listed in the source data as the pentadecapeptide component, GHK-Cu as the copper tripeptide component, TB-500 as the thymosin beta-4 component, and KPV as the tripeptide component. No additional mechanistic claims, efficacy claims, biological outcomes, or experimental conclusions are provided for this blend in the source record.
Research Background & Published Literature
The supplied research background for KL80 states that blend identity depends on component amount, purity, and COA data for each component, and that one CAS number, molecular formula, or molecular weight should not be assigned to the blend. No blend-specific citations are included in the provided research data, and no external peer-reviewed literature entries are supplied for this SKU.
Accordingly, this description does not infer blend-specific research outcomes from the names of the individual components. Researchers needing a literature review should treat BPC-157, GHK-Cu, TB-500, and KPV as separate component records and verify any published references through their own laboratory review process. Any discussion of mechanisms, assay models, or biological pathways should be supported by component-specific source material and should remain separate from unsupported claims about the four-component blend.
The source record identifies the raw Nexus catalog as the available source entry for this item. That catalog record supports the SKU, research size, category, component list, classification, physical form, intended use, and storage guidance. It does not support therapeutic activity, dosing, human use, veterinary use, disease treatment, diagnosis, disease prevention, or product performance claims in any biological system.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
- Matek et al. (2026) — Pharmaceuticals (Basel)
- Pickart (2008) — J Biomater Sci Polym Ed
- Pickart et al. (2012) — Oxid Med Cell Longev
- Goldstein et al. (2005) — Trends Mol Med
- Sosne et al. (2010) — FASEB J
- Land (2012) — Int J Physiol Pathophysiol Pharmacol
- Brzoska et al. (2010) — Adv Exp Med Biol
Storage, Handling & Stability Guidelines
Store lyophilized KL80 material at -20°C, desiccated, and protected from light. The source storage guidance further states that after reconstitution, material should be aliquoted and repeated freeze-thaw cycles should be avoided.
- Maintain the lyophilized material under the documented -20°C storage condition until it is needed for a validated laboratory workflow.
- Protect the material from moisture and light during storage and handling.
- After reconstitution, aliquot according to laboratory SOPs to reduce repeated freeze-thaw exposure.
- Use appropriate laboratory PPE and follow institutional chemical handling procedures for research reagents.
- Record product name, SKU, component amounts, reconstitution details, operator initials, and handling dates in internal logs where applicable.
The source record does not specify a post-reconstitution storage temperature, validated beyond-use interval, reconstitution diluent, concentration, assay-specific preparation protocol, or stability study. Those details should not be inferred from this product page.
Lab Verification
No exact COA data is provided for this Nexus-only blend in the source record. The available COA object contains no normalized purity, identity, batch, retention-time, mass, or component verification attributes. For that reason, this page does not list a purity percentage, batch number, test date, chromatographic retention time, or Mass Spectrometry result.
Nexus references lab verification records through the Lab Verified archive. Where current batch documentation is available, HPLC verification may be used in general terms to review chromatographic purity, and MS verification may be used in general terms to support molecular identity review. For KL80, any exact verification values should be taken only from the current batch COA or verified laboratory record, not inferred from the blend name or from component expectations.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Compounds are supplied as lyophilized research material — follow the storage and reconstitution guidance on the product page and its Certificate of Analysis.
Compound details.
- Class
- Multi-peptide blend
- Physical Form
- Lyophilized powder
- Storage
- Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Research context.
BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg is studied in preclinical research models examining mechanisms relevant to the tissue repair, immune modulation, and recovery-oriented research peptides. category. Independently verified Nexus Laboratory batches are documented through third-party HPLC purity verification, mass spectrometry identity confirmation, and endotoxin context where applicable; lots awaiting final documentation are labeled certificate pending. Compounds are supplied strictly for in-vitro and analytical research use.
Verification standard.
Independently verified Nexus Laboratory batches ship with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin context where applicable — verified by independent third-party laboratories and publicly archived; lots awaiting final documentation are labeled certificate pending instead of showing assay values. Review Nexus lab verification.
Certificate status.
Finalized independent certificate documentation is pending for this catalog record. Measurement details remain withheld until the certificate is available.
- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
Blend of BPC-157, GHK-Cu, TB-500, and KPV; no single molecular formula or molecular weight applies.
Storage: Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Technical specifications.
- Product Name: BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg
- Classification: Multi-peptide blend
- Structural Description: Blend of BPC-157, GHK-Cu, TB-500, and KPV; no single molecular formula or molecular weight applies.
- CAS Number: Not confirmed
- Molecular Weight: Not applicable / not confirmed
- Molecular Formula: Not applicable / not confirmed
- Physical Form: Lyophilized powder
- Intended Use: In-vitro research use only - not for human consumption
Related research compounds
Comparable catalog records with live availability and certificate status.
- Healing & RecoveryVerified batchBPC 157PriceFrom $30.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 137525-51-0View product - Healing & RecoveryVerified batchTB500 (Thymosin B4 Acetate)PriceFrom $30.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 77591-33-4View product - Healing & RecoveryCertificate pendingTB500 (FRAG)Price$60.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product - Healing & RecoveryVerified batchBPC 2mg + TB 2mgPrice$54.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product - Healing & RecoveryVerified batchBPC 5mg + TB 5mgPrice$80.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
View product
Research notes.
BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg research FAQ.
What is BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg used for in research?
BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg is supplied for controlled in-vitro research workflows in the Healing & Recovery category. It is not labeled for human or veterinary use.
Is BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg HPLC verified?
BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg is listed with certificate-pending status until a finalized independent COA record is available.
Which BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg sizes are available?
Current Nexus variants include 80mg.
Does BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg include a COA?
The current Nexus record marks BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg as certificate pending; finalized assay values are not shown until independent documentation is available.